Abstract
4/2019
vol. 57
Review paper
Rotenone: from modelling to implication in Parkinson’s disease
- Department of Pathology, College of Medicine, King Khalid University, Abha, Saudi Arabia
- Department of Pathology, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt
- Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Mansoura University, Egypt
- Department of Chinese Medicine, Xuanwu Hospital, Capital Medicine University, Beijing, China
- Department for Biomedical Sciences, Institute of Medical Biochemistry, University of Veterinary Medicine, Vienna, Austria
Folia Neuropathol 2019; 57 (4): 317-326
Online publish date: 2019/11/18
Rotenone ([2R-(2α,6aα,12aα)]-1,2,12,12a-tetrahydro-8,9-dimethoxy-2-(1-methylethenyl)-[1]benzopyran[3,4-b]furo [2,3-h][1]benzopyran-6(6aH)-one) is a naturally occurring compound derived from the roots and stems of Derris, Tephrosia, Lonchocarpus and Mundulea plant species. Since its discovery at the end of the 19th century, rotenone has been widely used as a pesticide for controlling insects, ticks and lice, and as a piscicide for management of nuisance fish in lakes and reservoirs. In 2000, Betarbet et al. reproduced most of the behavioural, biochemical and pathological features of Parkinson’s disease (PD) in rotenone-treated rats. Since that time, rotenone has received much attention as it would be one of the environmental neurotoxins implicated in etiopathogenesis of PD. Moreover, it represents a common experimental model to investigate the underlying mechanisms leading to PD and evaluate the new potential therapies for the disease. In the current general review, we aimed to address recent advances in the hazards of the environmental applications of rotenone and discuss the updates on the rotenone model of PD and whether it is implicated in the etiopathogenesis of the disease.
Keywords
rotenone, Parkinson’s disease, neurodegeneration, pesticides, piscicides
Integrated with